[#item_full_content]SAN FRANCISCO–(BUSINESS WIRE)–Komodo Health today unveiled findings from a new, first-of-its kind survey detailing the challenges…
Year: 2024
Focal Medical Receives FDA Clearance to Initiate Phase 1b Clinical Trial of ACT-IOP-003, a Targeted Therapeutic Product in Development for Pancreatic Cancer
[#item_full_content]CARY, N.C.–(BUSINESS WIRE)–Focal Medical, Inc., (“Focal”) a privately held biopharmaceutical company developing a targeted therapeutic system…